Profile of long COVID symptoms needing rehabilitation: a cross-sectional household survey of 12,925 SARS-CoV-2 cases between July and December 2021 in Bangladesh.
Bangladesh
C19-YRS
Epidemiology
Long COVID
Rehabilitation
Journal
Archives of public health = Archives belges de sante publique
ISSN: 0778-7367
Titre abrégé: Arch Public Health
Pays: England
ID NLM: 9208826
Informations de publication
Date de publication:
17 Jul 2023
17 Jul 2023
Historique:
received:
13
04
2023
accepted:
22
06
2023
medline:
18
7
2023
pubmed:
18
7
2023
entrez:
17
7
2023
Statut:
epublish
Résumé
It is important to determine the profile of long COVID (LC) symptoms within the scope of rehabilitation in Bangladesh. This study's objective was to estimate the newly experienced long COVID symptoms needing rehabilitation by determining the prevalence and spectrum of impairments due to LC in Bangladesh. A Cross-sectional household survey of 12,925 COVID-19 patients confirmed by RT-PCR from 24 testing facilities in Bangladesh. LC was diagnosed according to WHO working group definition. COVID-19 Yorkshire Rehabilitation Scale (C19-YRS) was used to determine the symptom responses, symptom severity, new long COVID symptoms, and scope of rehabilitation. The population proportion of LC symptoms requiring rehabilitation interventions are 0.22 [95% CI, 0.20-0.24] in Bangladeshi people diagnosed with SARS-CoV-2. Among them, 0.08 [95% CI, 0.07-0.09] had mild, 0.07 [95% CI, 0.06-0.09] had moderate, and 0.05 [95% CI, 0.04-0.06] had severe long COVID symptoms (LCS). There was a significant positive correlation between LCS and functional disabilities (r = 0.889, p < 0.001), while a negative correlation was observed between the severity of symptoms and overall health (r=-0.658, p < 0.001). In comparison to the pre-COVID status, 17 new LCS were observed and the increase in the scope of rehabilitation intervention among LCS ranged between 0.01 [95% CI, 0.001-0.01] and 0.21 [95% CI, 0.19-0.22]. In Bangladesh, 59% (n = 334) of the LC cases are out of reach for any rehabilitation interventions. Nearly one-fourth of Bangladeshi Post-COVID-19 have long COVID (LC). Seventeen symptoms (LCS) were observed and more than half of the populations having long COVID are out of reach of any rehabilitation facilities.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
It is important to determine the profile of long COVID (LC) symptoms within the scope of rehabilitation in Bangladesh. This study's objective was to estimate the newly experienced long COVID symptoms needing rehabilitation by determining the prevalence and spectrum of impairments due to LC in Bangladesh.
METHODS
METHODS
A Cross-sectional household survey of 12,925 COVID-19 patients confirmed by RT-PCR from 24 testing facilities in Bangladesh. LC was diagnosed according to WHO working group definition. COVID-19 Yorkshire Rehabilitation Scale (C19-YRS) was used to determine the symptom responses, symptom severity, new long COVID symptoms, and scope of rehabilitation.
RESULTS
RESULTS
The population proportion of LC symptoms requiring rehabilitation interventions are 0.22 [95% CI, 0.20-0.24] in Bangladeshi people diagnosed with SARS-CoV-2. Among them, 0.08 [95% CI, 0.07-0.09] had mild, 0.07 [95% CI, 0.06-0.09] had moderate, and 0.05 [95% CI, 0.04-0.06] had severe long COVID symptoms (LCS). There was a significant positive correlation between LCS and functional disabilities (r = 0.889, p < 0.001), while a negative correlation was observed between the severity of symptoms and overall health (r=-0.658, p < 0.001). In comparison to the pre-COVID status, 17 new LCS were observed and the increase in the scope of rehabilitation intervention among LCS ranged between 0.01 [95% CI, 0.001-0.01] and 0.21 [95% CI, 0.19-0.22]. In Bangladesh, 59% (n = 334) of the LC cases are out of reach for any rehabilitation interventions.
CONCLUSION
CONCLUSIONS
Nearly one-fourth of Bangladeshi Post-COVID-19 have long COVID (LC). Seventeen symptoms (LCS) were observed and more than half of the populations having long COVID are out of reach of any rehabilitation facilities.
Identifiants
pubmed: 37461092
doi: 10.1186/s13690-023-01140-0
pii: 10.1186/s13690-023-01140-0
pmc: PMC10351147
doi:
Types de publication
Journal Article
Langues
eng
Pagination
132Informations de copyright
© 2023. The Author(s).
Références
J Occup Rehabil. 2023 Jun;33(2):227-230
pubmed: 36315323
Health Sci Rep. 2021 Sep 08;4(3):e366
pubmed: 34522791
Ann Med. 2022 Dec;54(1):1473-1487
pubmed: 35594336
Ann Med Surg (Lond). 2022 Mar;75:103361
pubmed: 35186286
Int J Environ Res Public Health. 2022 Apr 22;19(9):
pubmed: 35564488
J Med Virol. 2022 Apr;94(4):1419-1427
pubmed: 34783052
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221133001
pubmed: 36214233
BMJ. 2021 Jul 26;374:n1648
pubmed: 34312178
J Rehabil Med. 2020 Aug 24;52(8):jrm00089
pubmed: 32830284
Nat Commun. 2022 Apr 5;13(1):1812
pubmed: 35383197
BMJ. 2022 Sep 22;378:e072117
pubmed: 36137612
Nat Med. 2022 Jun;28(6):1139-1140
pubmed: 35606552
Lancet Infect Dis. 2021 May;21(5):601-602
pubmed: 33548193
Lancet Infect Dis. 2022 Apr;22(4):e102-e107
pubmed: 34951953
J Med Virol. 2022 Mar;94(3):1027-1034
pubmed: 34676578
BMJ Glob Health. 2021 Dec;6(12):
pubmed: 34906986
J Patient Exp. 2022 Aug 5;9:23743735221117358
pubmed: 35957651
J Infect Dis. 2022 Nov 1;226(9):1593-1607
pubmed: 35429399